The epigenetic gene PR domain zinc finger protein 1 (PRDM1) knockdown in T cells showed an increased chromatin accessibility and promoted the expansion of memory CAR‐T cells, which enhanced T cell durability and improved the efficacy of cancer immunotherapy and improved survival rate.196. This evidence concerns the gene PRDM1 and cancer.